Compounds > lidocaine
Page last updated: 2024-10-28

lidocaine and Postherpetic Neuralgia

lidocaine has been researched along with Postherpetic Neuralgia in 87 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research Excerpts

ExcerptRelevanceReference
"DSA-guided nerve pulse radiofrequency surgery combined with intravenous lidocaine infusion can effectively relieve pain in patients diagnosed with herpes zoster nerves at the subacute stage, reduce the number of analgesic drugs used in patients, reduce postherpetic neuralgia incidence rate, and improve sleep and quality of life."9.51Clinical Efficacy of Pulsed Radiofrequency Combined with Intravenous Lidocaine Infusion in the Treatment of Subacute Herpes Zoster Neuralgia. ( He, C; Zhang, W, 2022)
"This study evaluated the analgesic efficacy and emotional response to intravenous lidocaine infusion compared with placebo in patients with postherpetic neuralgia (PHN)."9.27The Analgesic and Emotional Response to Intravenous Lidocaine Infusion in the Treatment of Postherpetic Neuralgia: A Randomized, Double-Blinded, Placebo-controlled Study. ( Li, J; Liu, H; Lu, F; Song, L; Xiao, H; Yang, B; Ye, L; Yin, Y; Zhou, D, 2018)
"Subcutaneous injection, lidocaine, triamcinolone, postherpetic neuralgia, prevention."9.24Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia. ( Guo, Y; Ni, J; Tang, Y; Wang, X; Yang, L; Zeng, Y, 2017)
"Sixty-four elderly patients with herpes zoster were randomized to receive a 10-day course of intradermal injection of methylene blue and lidocaine plus oral valaciclovir (group A, 32 cases) and intradermal injection of lidocaine plus oral valaciclovir (group B)."9.22[Efficacy of intracutaneous methylene blue injection for moderate to severe acute thoracic herpes zoster pain and prevention of postherpetic neuralgia in elderly patients]. ( Cui, JZ; Ma, ZL; Zhang, JW; Zhang, Y, 2016)
"To determine the impact of 5% lidocaine-medicated plasters on sleep, quality of life and pain in 265 patients with postherpetic neuralgia (PHN)."9.22Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia. ( Baron, R; Binder, A; Hans, G; Rogers, P, 2016)
"High efficacy of intrathecal methylprednisolone acetate (MPA) with lidocaine has been reported in a large patient group suffering from intractable postherpetic neuralgia (PHN)."9.17No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. ( Kalkman, CJ; Kavelaars, A; Meulenhoff, PC; Rijsdijk, M; van der Tweel, I; van Wijck, AJ, 2013)
"In patients with PHN and painful DPN failing to respond to monotherapy, combination therapy with 5% lidocaine medicated plaster and pregabalin provides additional clinically relevant pain relief and is safe and well-tolerated."9.14Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. ( Baron, R; Binder, A; Leijon, G; Mayoral, V; Serpell, M; Steigerwald, I, 2009)
" Data are reported from the initial 4-week comparative phase, in which adults with PHN or painful DPN received either topical 5% lidocaine medicated plaster applied to the most painful skin area or twice-daily pregabalin capsules titrated to effect according to the Summary of Product Characteristics."9.145% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. ( Baron, R; Binder, A; Leijon, G; Mayoral, V; Serpell, M; Steigerwald, I, 2009)
"Published analyses have demonstrated that the lidocaine (lignocaine) plaster is a cost-effective treatment for postherpetic neuralgia (PHN) relative to gabapentin or pregabalin."9.14Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis. ( Liedgens, H; Nuijten, M; Ritchie, M, 2010)
"Topical lidocaine (LDC) treatment using a gel or patch preparation is effective in the treatment of postherpetic neuralgia (PHN), but neither is suited for the eye in patients with ophthalmic PHN."9.14Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia. ( Kanai, A; Niki, Y; Okamoto, H; Okamoto, T; Suzuki, K, 2010)
"Locally infiltrated injection triamcinolone acetonide with lignocaine was significantly more effective than injection lignocaine alone in the treatment of postherpetic neuralgia both at 6 and 12 weeks follow-up."9.11The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia. ( Amjad, M; Mashhood, AA, 2005)
"The purpose of this study was to compare the cost effectiveness of a new 8% capsaicin patch, compared to the current treatments for postherpetic neuralgia (PHN), including tricyclic antidepressants (TCAs), topical lidocaine patches, duloxetine, gabapentin, and pregabalin."8.87Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia. ( Armstrong, EP; Malone, DC; McCarberg, B; Panarites, CJ; Pham, SV, 2011)
"To examine the efficacy and safety of topical lidocaine in the treatment of postherpetic neuralgia."8.84Topical lidocaine for the treatment of postherpetic neuralgia. ( Alam, S; Khaliq, W; Puri, N, 2007)
"To provide a basis for treating postherpetic neuralgia (PHN), we compared the efficacy of lidocaine and ropivacaine stellate ganglion block (SGB) in PHN treatment in the upper limbs."8.12Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia. ( Chen, H; Fan, Z; Li, D; Li, L; Zheng, X, 2022)
"To investigate short- and long-term effectiveness and safety of the 5% lidocaine medicated plaster in the treatment of postherpetic neuralgia (PHN) in elderly patients (≥70 years of age)."7.85Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials. ( Baron, R; Bösl, I; Buchheister, B; König, S; Meier, T; Sabatowski, R, 2017)
"To compare demographic and comorbidity profiles and healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% (lidocaine patch) versus patients not treated with the lidocaine patch."7.76Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. ( Amy Puenpatom, R; Ben-Joseph, RH; Birnbaum, HG; Ivanova, JI; Kantor, E; Kirson, NY; Summers, KH; Wei, R, 2010)
"To compare healthcare resource utilization and costs of postherpetic neuralgia (PHN) patients initiating lidocaine patch 5% (lidocaine patch) or oral gabapentin/pregabalin."7.76Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. ( Ben-Joseph, RH; Birnbaum, HG; Ivanova, JI; Kantor, E; Kirson, NY; Puenpatom, RA; Summers, KH; Wei, R, 2010)
"This study set out to assess the cost effectiveness of using a 5% lidocaine (lignocaine) medicated plaster for the treatment of postherpetic neuralgia (PHN) compared with gabapentin, pregabalin 300 mg/day or 600 mg/day in German primary care."7.74Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective. ( Dakin, H; Gabriel, A; Hertel, N; Liedgens, H; Mitchell, S; Nautrup, BP; Nuijten, M, 2008)
"Both gabapentin and pregabalin are approved for the management of postherpetic neuralgia (PHN), although dosing and pharmacokinetic differences between these medications may affect their use in actual practice."7.74A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. ( Gore, M; Sadosky, A; Stacey, B; Tai, KS, 2007)
"Chronic pain is currently considered a disease state with biopsychosocial consequences and a negative impact on patients' quality of life (QoL)."6.82Changing the paradigm in postherpetic neuralgia treatment: lidocaine 700 mg medicated plaster. ( Fornasari, D; Magni, A; Pais, P; Palao, T; Polati, E; Sansone, P, 2022)
"Overall, administration of KAI-1678 was generally safe and well tolerated."6.78The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design. ( Bell, G; Cousins, MJ; Critchley, L; Huang, S; Pickthorn, K, 2013)
"Treatment of chronic pain conditions is commonly assessed at specific endpoints at preset times during or after treatment by analysis of the total study population."6.78A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. ( Dahan, A; Krebs-Brown, A; Martini, CH; Olofsen, E; Passier, P; Stoker, M; Yassen, A, 2013)
" Safety parameters (clinical examination, skin evaluation, laboratory) and adverse events (AEs) were assessed at regular visits."6.77Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. ( Baron, R; Buchheister, B; Hans, G; Kapanadze, S; Sabatowski, R; Tacken, I, 2012)
"Lidocaine plaster was also effective in reducing worst pain and showed a fast onset of effect."6.75Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. ( Baron, R; Binder, A; Rehm, S, 2010)
" Drug-related adverse events occurred in 13."6.74Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. ( Baron, R; Binder, A; Bösl, I; Bruxelle, J; Hans, G; Rogers, P, 2009)
"Postherpetic neuralgia (PHN) and diabetic polyneuropathy (DPN) are two common causes of peripheral neuropathic pain."6.74Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. ( Baron, R; Binder, A; Leijon, G; Mayoral, V; Serpell, M; Steigerwald, I, 2009)
"1%) were treated with at least one PHN concomitant medication, for which the number and dosing remained constant during the study."5.72Lidocaine 700 mg medicated plaster for post-herpetic neuralgia: focus on Quality of Life, effectiveness and safety - a retrospective observational study. ( Aurilio, C; Coppolino, F; Giaccari, LG; Pace, MC; Passavanti, MB; Pota, V; Sansone, P, 2022)
"Lay abstract Postherpetic neuralgia is the most common complication of shingles."5.72Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry. ( Bösl, I; Eerdekens, M; Hollanders, E; Sabatschus, I; Überall, MA, 2022)
"Herpes zoster is often associated to acute neuralgia and postherpetic neuralgia (PHN)."5.62Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia. ( Bianchi, L; Gori, F; Hansel, K; Marietti, R; Piergiovanni, C; Renzini, M; Stingeni, L; Tramontana, M, 2021)
"DSA-guided nerve pulse radiofrequency surgery combined with intravenous lidocaine infusion can effectively relieve pain in patients diagnosed with herpes zoster nerves at the subacute stage, reduce the number of analgesic drugs used in patients, reduce postherpetic neuralgia incidence rate, and improve sleep and quality of life."5.51Clinical Efficacy of Pulsed Radiofrequency Combined with Intravenous Lidocaine Infusion in the Treatment of Subacute Herpes Zoster Neuralgia. ( He, C; Zhang, W, 2022)
"Lidocaine plaster treatment resulted in a significant mean reduction of one concomitant PHN treatment per patient in the overall efficacy population analysed at the end of the observation (p < 0."5.375% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France. ( Clère, F; Delorme-Morin, C; Ganry, H; George, B; Navez, M; Rioult, B; Tiberghien-Chatelain, F, 2011)
"This study evaluated the analgesic efficacy and emotional response to intravenous lidocaine infusion compared with placebo in patients with postherpetic neuralgia (PHN)."5.27The Analgesic and Emotional Response to Intravenous Lidocaine Infusion in the Treatment of Postherpetic Neuralgia: A Randomized, Double-Blinded, Placebo-controlled Study. ( Li, J; Liu, H; Lu, F; Song, L; Xiao, H; Yang, B; Ye, L; Yin, Y; Zhou, D, 2018)
"Subcutaneous injection, lidocaine, triamcinolone, postherpetic neuralgia, prevention."5.24Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia. ( Guo, Y; Ni, J; Tang, Y; Wang, X; Yang, L; Zeng, Y, 2017)
"To determine the impact of 5% lidocaine-medicated plasters on sleep, quality of life and pain in 265 patients with postherpetic neuralgia (PHN)."5.22Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia. ( Baron, R; Binder, A; Hans, G; Rogers, P, 2016)
"Sixty-four elderly patients with herpes zoster were randomized to receive a 10-day course of intradermal injection of methylene blue and lidocaine plus oral valaciclovir (group A, 32 cases) and intradermal injection of lidocaine plus oral valaciclovir (group B)."5.22[Efficacy of intracutaneous methylene blue injection for moderate to severe acute thoracic herpes zoster pain and prevention of postherpetic neuralgia in elderly patients]. ( Cui, JZ; Ma, ZL; Zhang, JW; Zhang, Y, 2016)
"Ninety patients (≥50 yrs old) with postherpetic neuralgia with a pain score of 4 or greater were randomized to receive TENS and local injections of cobalamin or lidocaine or a combination of cobalamin and lidocaine for 8 wks."5.19Transcutaneous electrical nerve stimulation in combination with cobalamin injection for postherpetic neuralgia: a single-center randomized controlled trial. ( Feng, Y; Lv, ZW; Tang, WZ; Xu, G, 2014)
"High efficacy of intrathecal methylprednisolone acetate (MPA) with lidocaine has been reported in a large patient group suffering from intractable postherpetic neuralgia (PHN)."5.17No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. ( Kalkman, CJ; Kavelaars, A; Meulenhoff, PC; Rijsdijk, M; van der Tweel, I; van Wijck, AJ, 2013)
"In patients with PHN and painful DPN failing to respond to monotherapy, combination therapy with 5% lidocaine medicated plaster and pregabalin provides additional clinically relevant pain relief and is safe and well-tolerated."5.14Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. ( Baron, R; Binder, A; Leijon, G; Mayoral, V; Serpell, M; Steigerwald, I, 2009)
" Data are reported from the initial 4-week comparative phase, in which adults with PHN or painful DPN received either topical 5% lidocaine medicated plaster applied to the most painful skin area or twice-daily pregabalin capsules titrated to effect according to the Summary of Product Characteristics."5.145% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. ( Baron, R; Binder, A; Leijon, G; Mayoral, V; Serpell, M; Steigerwald, I, 2009)
"Twenty patients with localized neuropathic pain [postoperative neuropathic pain (n = 14); complex regional pain syndrome (n = 2); and postherpetic neuralgia (n = 4)], who had been successfully treated with 5% lidocaine medicated plaster, were followed up by telephone interview after 3 and 5 years."5.14Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. ( Griessinger, N; Likar, R; Sittl, R; Tzabazis, A; Wilhelm, IR, 2010)
"Published analyses have demonstrated that the lidocaine (lignocaine) plaster is a cost-effective treatment for postherpetic neuralgia (PHN) relative to gabapentin or pregabalin."5.14Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis. ( Liedgens, H; Nuijten, M; Ritchie, M, 2010)
"Topical lidocaine (LDC) treatment using a gel or patch preparation is effective in the treatment of postherpetic neuralgia (PHN), but neither is suited for the eye in patients with ophthalmic PHN."5.14Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia. ( Kanai, A; Niki, Y; Okamoto, H; Okamoto, T; Suzuki, K, 2010)
"Locally infiltrated injection triamcinolone acetonide with lignocaine was significantly more effective than injection lignocaine alone in the treatment of postherpetic neuralgia both at 6 and 12 weeks follow-up."5.11The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia. ( Amjad, M; Mashhood, AA, 2005)
" In patients with neuropathic pain, topical forms of both capsaicin and lidocaine have been shown to be useful in the treatment of postherpetic neuralgia and diabetic peripheral neuropathic pain."4.89Topical therapies in the management of chronic pain. ( Galluzzi, KE; Stanos, SP, 2013)
"The purpose of this study was to compare the cost effectiveness of a new 8% capsaicin patch, compared to the current treatments for postherpetic neuralgia (PHN), including tricyclic antidepressants (TCAs), topical lidocaine patches, duloxetine, gabapentin, and pregabalin."4.87Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia. ( Armstrong, EP; Malone, DC; McCarberg, B; Panarites, CJ; Pham, SV, 2011)
"To examine the efficacy and safety of topical lidocaine in the treatment of postherpetic neuralgia."4.84Topical lidocaine for the treatment of postherpetic neuralgia. ( Alam, S; Khaliq, W; Puri, N, 2007)
"To provide a basis for treating postherpetic neuralgia (PHN), we compared the efficacy of lidocaine and ropivacaine stellate ganglion block (SGB) in PHN treatment in the upper limbs."4.12Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia. ( Chen, H; Fan, Z; Li, D; Li, L; Zheng, X, 2022)
"Based on clinical study results, 5% lidocaine-medicated plaster (5% LMP) is currently recommended for the treatment of localized peripheral neuropathic pain, such as post-herpetic neuralgia (PHN)."3.85Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study. ( Amato, F; Ciliberto, G; Consoletti, L; Duse, G; Firetto, V; Lo Presti, C; Mazza, M; Palmieri, V; Parigi, LA, 2017)
"To investigate short- and long-term effectiveness and safety of the 5% lidocaine medicated plaster in the treatment of postherpetic neuralgia (PHN) in elderly patients (≥70 years of age)."3.85Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials. ( Baron, R; Bösl, I; Buchheister, B; König, S; Meier, T; Sabatowski, R, 2017)
"To compare healthcare resource utilization and costs of postherpetic neuralgia (PHN) patients initiating lidocaine patch 5% (lidocaine patch) or oral gabapentin/pregabalin."3.76Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. ( Ben-Joseph, RH; Birnbaum, HG; Ivanova, JI; Kantor, E; Kirson, NY; Puenpatom, RA; Summers, KH; Wei, R, 2010)
"To compare demographic and comorbidity profiles and healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% (lidocaine patch) versus patients not treated with the lidocaine patch."3.76Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. ( Amy Puenpatom, R; Ben-Joseph, RH; Birnbaum, HG; Ivanova, JI; Kantor, E; Kirson, NY; Summers, KH; Wei, R, 2010)
"This study set out to assess the cost effectiveness of using a 5% lidocaine (lignocaine) medicated plaster for the treatment of postherpetic neuralgia (PHN) compared with gabapentin, pregabalin 300 mg/day or 600 mg/day in German primary care."3.74Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective. ( Dakin, H; Gabriel, A; Hertel, N; Liedgens, H; Mitchell, S; Nautrup, BP; Nuijten, M, 2008)
"Both gabapentin and pregabalin are approved for the management of postherpetic neuralgia (PHN), although dosing and pharmacokinetic differences between these medications may affect their use in actual practice."3.74A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. ( Gore, M; Sadosky, A; Stacey, B; Tai, KS, 2007)
"Postherpetic neuralgia is an annoying pain that mainly affects older people."3.01Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives. ( Liu, C; Song, L; Tang, J; Zeng, A; Zhang, Y, 2023)
"Local methylcobalamin combined with lidocaine, optimally administered within 4-7 days of onset, may be an effective therapeutic option for acute herpetic neuralgia."2.82Local Injection of Methylcobalamin Combined with Lidocaine for Acute Herpetic Neuralgia. ( Cheng, C; Tang, WZ; Xǔ, G; Xu, J; Xu, S, 2016)
"Chronic pain is currently considered a disease state with biopsychosocial consequences and a negative impact on patients' quality of life (QoL)."2.82Changing the paradigm in postherpetic neuralgia treatment: lidocaine 700 mg medicated plaster. ( Fornasari, D; Magni, A; Pais, P; Palao, T; Polati, E; Sansone, P, 2022)
"Overall, administration of KAI-1678 was generally safe and well tolerated."2.78The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design. ( Bell, G; Cousins, MJ; Critchley, L; Huang, S; Pickthorn, K, 2013)
"Treatment of chronic pain conditions is commonly assessed at specific endpoints at preset times during or after treatment by analysis of the total study population."2.78A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. ( Dahan, A; Krebs-Brown, A; Martini, CH; Olofsen, E; Passier, P; Stoker, M; Yassen, A, 2013)
" Safety parameters (clinical examination, skin evaluation, laboratory) and adverse events (AEs) were assessed at regular visits."2.77Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. ( Baron, R; Buchheister, B; Hans, G; Kapanadze, S; Sabatowski, R; Tacken, I, 2012)
"Lidocaine plaster was also effective in reducing worst pain and showed a fast onset of effect."2.75Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. ( Baron, R; Binder, A; Rehm, S, 2010)
" Drug-related adverse events occurred in 13."2.74Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. ( Baron, R; Binder, A; Bösl, I; Bruxelle, J; Hans, G; Rogers, P, 2009)
"Postherpetic neuralgia (PHN) and diabetic polyneuropathy (DPN) are two common causes of peripheral neuropathic pain."2.74Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. ( Baron, R; Binder, A; Leijon, G; Mayoral, V; Serpell, M; Steigerwald, I, 2009)
"Lidocaine is a local anaesthetic that is sometimes used on the skin to treat neuropathic pain."2.50Topical lidocaine for neuropathic pain in adults. ( Derry, S; Moore, RA; Quinlan, J; Wiffen, PJ, 2014)
"Postherpetic neuralgia is considered to be a neuropathic pain syndrome."2.50[Postherpetic neuralgia]. ( Goßrau, G, 2014)
"Herpes zoster has been associated with several complications, of which post-herpetic neuralgia (PHN) is the most common and debilitating."2.49Herpes zoster: diagnostic, therapeutic, and preventive approaches. ( Bader, MS, 2013)
"Herpes zoster (HZ), commonly called shingles, is a distinctive syndrome caused by reactivation of varicella zoster virus (VZV)."2.45Herpes zoster (shingles) and postherpetic neuralgia. ( Drage, LA; Martin, DP; Sampathkumar, P, 2009)
"Lidocaine plaster treatment resulted in superior pain relief, significantly fewer restrictions in daily life activities and better quality of life than the oral medications evaluated and was significantly better tolerated."1.72Localized peripheral neuropathic pain: topical treatment with lidocaine 700 mg medicated plaster in routine clinical practice. ( Bösl, I; Eerdekens, M; Hollanders, E; Sabatschus, I; Überall, MA, 2022)
"Lay abstract Postherpetic neuralgia is the most common complication of shingles."1.72Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry. ( Bösl, I; Eerdekens, M; Hollanders, E; Sabatschus, I; Überall, MA, 2022)
"1%) were treated with at least one PHN concomitant medication, for which the number and dosing remained constant during the study."1.72Lidocaine 700 mg medicated plaster for post-herpetic neuralgia: focus on Quality of Life, effectiveness and safety - a retrospective observational study. ( Aurilio, C; Coppolino, F; Giaccari, LG; Pace, MC; Passavanti, MB; Pota, V; Sansone, P, 2022)
"Herpes zoster is often associated to acute neuralgia and postherpetic neuralgia (PHN)."1.62Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia. ( Bianchi, L; Gori, F; Hansel, K; Marietti, R; Piergiovanni, C; Renzini, M; Stingeni, L; Tramontana, M, 2021)
"Localized neuropathic pain (LNP) is a subgroup of neuropathic pain characterized by consistent and circumscribed area(s) of maximum pain, associated with negative or positive sensory signs and/or spontaneous symptoms characteristic of NP."1.48Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy. ( Chinellato, E; Del Balzo, G; Martini, A; Parolini, M; Picelli, A; Polati, E; Schweiger, V; Tamburin, S; Zanzotti, M, 2018)
"Postherpetic neuralgia is a common and challenging complication of herpes zoster infection, particularly in older people."1.43Ultrasound-Guided Musculocutaneous Nerve Block in Postherpetic Neuralgia. ( Chiou, HJ; Hsieh, LF; Kuo, YC, 2016)
"The treatment of neuropathic pain is a medical challenge."1.40[Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain]. ( Chiarlone, R; Fogliardi, A; Intelligente, F; Irace, C; Lanzilotta, M; Lattanzi, S; Palomba, R; Provinciali, L; Storelli, E; Zampi, M, 2014)
"Lidocaine plaster treatment resulted in a significant mean reduction of one concomitant PHN treatment per patient in the overall efficacy population analysed at the end of the observation (p < 0."1.375% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France. ( Clère, F; Delorme-Morin, C; Ganry, H; George, B; Navez, M; Rioult, B; Tiberghien-Chatelain, F, 2011)

Research

Studies (87)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's21 (24.14)29.6817
2010's50 (57.47)24.3611
2020's16 (18.39)2.80

Authors

AuthorsStudies
Überall, MA2
Bösl, I6
Hollanders, E4
Sabatschus, I4
Eerdekens, M4
Giaccari, LG1
Aurilio, C1
Coppolino, F1
Pace, MC1
Passavanti, MB1
Pota, V1
Sansone, P2
Zhang, W1
He, C1
Fornasari, D1
Magni, A1
Pais, P1
Palao, T1
Polati, E2
Fan, Z1
Zheng, X1
Li, D1
Chen, H1
Li, L1
A Überall, M1
Überall, M1
Tang, J1
Zhang, Y2
Liu, C1
Zeng, A1
Song, L2
Gudin, J1
Fudin, J1
Wang, E1
Haylon, T1
Patel, K1
Goss, TF1
Xu, G7
Zhou, CS1
Tang, WZ4
Xu, J3
Cheng, C3
Wang, LD1
Ding, KH1
Smith, A1
Doran, S1
Daly, M1
Kennedy, C1
Barry, M1
Jeon, Y1
Jin, Y1
Liu, X1
Wei, L1
Zeng, Q1
Lin, K1
Zhang, J1
Bianchi, L1
Piergiovanni, C1
Marietti, R1
Renzini, M1
Gori, F1
Hansel, K1
Tramontana, M1
Stingeni, L1
Liao, YM1
Lu, HF1
Xie, P1
Zhao, Y1
Han, Q1
Zhang, QX1
Zuo, XH1
Si, YN1
Bao, HG1
Zeng, F1
Wang, M1
Zhang, D2
Ni, J1
Wang, X1
Tang, Y1
Yang, L1
Zeng, Y1
Guo, Y1
Amato, F1
Duse, G1
Consoletti, L1
Lo Presti, C1
Firetto, V1
Ciliberto, G1
Parigi, LA1
Palmieri, V1
Mazza, M1
Kontić, M1
Vičić-Hudorović, V1
Hudorović, N1
Liu, H1
Lu, F1
Zhou, D1
Yin, Y1
Li, J1
Yang, B1
Ye, L1
Xiao, H1
Assier, H1
Wolkenstein, P1
Chosidow, O1
Martini, A1
Del Balzo, G1
Schweiger, V1
Zanzotti, M1
Picelli, A1
Parolini, M1
Chinellato, E1
Tamburin, S1
Kern, KU1
Schwickert-Nieswandt, M1
Moulin, DE1
Morley-Forster, PK1
Pirani, Z1
Rohfritsch, C1
Stitt, L1
Cousins, MJ1
Pickthorn, K1
Huang, S1
Critchley, L1
Bell, G1
Martini, CH1
Yassen, A1
Krebs-Brown, A1
Passier, P1
Stoker, M1
Olofsen, E1
Dahan, A1
Bader, MS1
Khaliq, W2
Alam, S2
Puri, NK1
Feng, Y1
Lv, ZW1
Fogliardi, A2
Brunori, C1
McCarberg, B2
D'Arcy, Y1
Stanos, SP1
Galluzzi, KE1
Goßrau, G1
Derry, S1
Wiffen, PJ1
Moore, RA1
Quinlan, J1
Johnson, RW1
Rice, AS1
Provinciali, L1
Lattanzi, S1
Chiarlone, R1
Intelligente, F1
Irace, C1
Lanzilotta, M1
Palomba, R1
Storelli, E1
Zampi, M1
Laurent, B1
Vicaut, E1
Leplège, A1
Bloch, K1
Leutenegger, E1
Malec-Milewska, M1
Horosz, B1
Sękowska, A1
Kolęda, I1
Kucia, H1
Kosson, D1
X, G1
Xu, S2
Kuo, YC1
Hsieh, LF1
Chiou, HJ1
Binder, A7
Rogers, P3
Hans, G4
Baron, R10
Cui, JZ1
Zhang, JW1
Ma, ZL1
Huang, J1
Ni, Z1
Finch, P1
Sabatowski, R3
König, S1
Buchheister, B2
Meier, T1
Bursi, R1
Piana, C1
Grevel, J1
Huntjens, D1
Boesl, I2
Liedgens, H3
Hertel, N1
Gabriel, A1
Nuijten, M3
Dakin, H2
Mitchell, S1
Nautrup, BP2
Mochizuki, N1
Ide, S1
Shibata, J1
Hasegawa, J1
Tanaka, S1
Ikeno, S1
Kitoh, T1
Kawamata, M1
Sampathkumar, P1
Drage, LA1
Martin, DP1
Mayoral, V3
Leijon, G3
Steigerwald, I3
Serpell, M3
Bruxelle, J1
Garroway, N1
Chhabra, S1
Landis, S1
Skolnik, DC1
Garnock-Jones, KP1
Keating, GM1
Wilhelm, IR1
Tzabazis, A1
Likar, R1
Sittl, R1
Griessinger, N1
Ritchie, M1
Kanai, A1
Okamoto, T1
Suzuki, K1
Niki, Y1
Okamoto, H1
Rehm, S1
Kirson, NY2
Ivanova, JI2
Birnbaum, HG2
Wei, R2
Kantor, E2
Puenpatom, RA1
Ben-Joseph, RH2
Summers, KH2
Amy Puenpatom, R1
Wolff, RF1
Bala, MM1
Westwood, M1
Kessels, AG1
Kleijnen, J1
Xiao, L1
Mackey, S1
Hui, H1
Xong, D1
Zhang, Q1
Armstrong, EP1
Malone, DC1
Panarites, CJ1
Pham, SV1
Eker, HE1
Yalçın Çok, O1
Açıl, M1
Ülger, H1
Arıboğan, A1
Argoff, CE1
Clère, F1
Delorme-Morin, C1
George, B1
Navez, M1
Rioult, B1
Tiberghien-Chatelain, F1
Ganry, H1
Puri, N2
Mick, G1
Correa-Illanes, G1
Tacken, I1
Kapanadze, S1
Lu, J1
Katano, T1
Nishimura, W1
Fujiwara, S1
Miyazaki, S1
Okasaki, I1
Aritake, K1
Urade, Y1
Minami, T1
Ito, S1
Rijsdijk, M1
van Wijck, AJ1
Meulenhoff, PC1
Kavelaars, A1
van der Tweel, I1
Kalkman, CJ1
Amjad, M1
Mashhood, AA1
Wasner, G1
Alper, BS1
Lewis, PR1
Dworkin, RH1
Jensen, MP1
Gammaitoni, AR1
Olaleye, DO1
Galer, BS1
Geha, PY1
Baliki, MN1
Chialvo, DR1
Harden, RN1
Paice, JA1
Apkarian, AV1
Gore, M1
Sadosky, A1
Tai, KS1
Stacey, B1
Tyring, SK1
Rosielle, DA1

Clinical Trials (14)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin[NCT01669967]34 participants (Actual)Interventional2011-09-30Completed
Randomized Comparative Open Trial of Occlusive Therapy With a Hydrocolloid or Silicone Versus Conventional Drying Treatment for the Local Care of Acute Lesions Caused by Herpes Zoster.[NCT04258930]36 participants (Anticipated)Interventional2020-02-26Recruiting
Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)[NCT03199417]Phase 2/Phase 350 participants (Actual)Interventional2017-05-01Terminated (stopped due to Terminated prematurely due to feasibility issues with rate of recruitment)
Efficacy of Electroacupuncture Therapy in Patients With Postherpetic Neuralgia: a Multicentre Randomised Controlled Trial[NCT04594226]132 participants (Actual)Interventional2020-11-11Completed
Prophylactic Duloxetine Administration During Acute Herpes Zoster Prevents Postherpetic Neuralgia[NCT04313335]750 participants (Anticipated)Interventional2021-03-01Recruiting
Safety and Efficacy of Lidocaine 5% Medicated Plaster in Comparison to Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain.[NCT00414349]Phase 3431 participants (Actual)Interventional2006-12-31Completed
An Open-label, Multicenter, Multiple-dose, Phase III Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia[NCT03765697]Phase 3259 participants (Actual)Interventional2003-07-16Completed
A Double-blind, Multicentre, Multiple-dose, Enriched Enrolment, Randomized-withdrawal, Parallel-group Phase III Study With Lido-Patch and Corresponding Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)[NCT03745404]Phase 3265 participants (Actual)Interventional2003-04-29Completed
VERSATIS - Efficacy and Safety of Lidocaine 5% Plasters (Versatis® 5%) in Child, Adolescents and Young Adults With Neuropathic Pains or Vasoocclusive Sickle Cell Crisis Pains[NCT01314300]Phase 239 participants (Anticipated)Interventional2011-03-31Completed
Subcutaneous Injection of Botulinum Toxin A for At--Level Back Pain in Patients With Spinal Cord Injury[NCT02736890]Phase 28 participants (Actual)Interventional2016-03-31Terminated (stopped due to funding not available to continue)
The Safety and Efficacy of 5% Lidocaine Patch and Flurbiprofen Patch for Relieving Acute Low Back Pain[NCT03171987]Phase 4120 participants (Anticipated)Interventional2017-06-14Recruiting
Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.[NCT06030297]301 participants (Anticipated)Interventional2022-11-01Recruiting
Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®[NCT03720119]78 participants (Actual)Observational2015-01-27Completed
Does Repetitive Peripheral Nerve Blocks Vs Single Peripheral Nerve Block Vs Standard Medical Treatment Provide a Better Pain Relief on Zoster Pain at the Acute Phase and Reduce the Risk of Post Herpetic Neuralgia?[NCT04133142]0 participants (Actual)Interventional2020-05-15Withdrawn (stopped due to No enrollement and covid)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

7-Point Guy/Farrar Patient Global Impression of Change (PGIC)

"Mean change from baseline. Participants are asked Taking into account your pain level and how it affects your life, are you feeling better, the same or worse than when you started treatment? and then to quantify the magnitude of the change. with the 7-Point guy Farrar which measures the global treatment effect from with scale from 0 to 6, higher score indicates worse outcomes." (NCT02736890)
Timeframe: up to 12 weeks post-injection, for a total of 24 weeks from baseline

,
Interventionscore on a scale (Mean)
2 week post injection4 week post injection8 week post injection12 week post injectioncrossover 2 week follow upcrossover 4 week follow upcrossover 8 week follow upcrossover 12 week follow up
Botulinum Toxin A Then Placebo2.22.4220000
Placebo Then Botulinum Toxin A0.30.3005531

International Basic Pain Dataset - Pain Affecting Day-to-day Activities

The International Basic Pain Dataset is an assessment tool which includes several components including: location of pain, temporal qualities of the pain, type of pain, pain interference measures of activity, sleep, and mood. It has been shown to be valid in an interview/self -report format. The pain affecting day-to-day activities subset of the dataset is scored is from 0 to 10, with higher score indicating less favorable outcomes. (NCT02736890)
Timeframe: up to 12 weeks post-injection, for a total of 24 weeks from baseline

,
Interventionunits on a scale (Mean)
Baseline2 week post injection4 week post injection8 week post injection12 week post injectioncrossover 2 week follow upcrossover 4 week follow upcrossover 8 week follow upcrossover 12 week follow up
Botulinum Toxin A Then Placebo4.25.4554.876.776.7
Placebo Then Botulinum Toxin A5.32.72.72.72.72345

International Basic Pain Dataset - Pain Affecting Mood

The International Basic Pain Dataset is an assessment tool which includes several components including: location of pain, temporal qualities of the pain, type of pain, pain interference measures of activity, sleep, and mood. It has been shown to be valid in an interview/self -report format. The pain affecting mood subset of the dataset is scored is from 0 to 10, with higher score indicating less favorable outcomes. (NCT02736890)
Timeframe: up to 12 weeks post-injection, for a total of 24 weeks from baseline

,
Interventionunits on a scale (Mean)
Baseline2 week post injection4 week post injection8 week post injection12 week post injectioncrossover 2 week follow upcrossover 4 week follow upcrossover 8 week follow upcrossover 12 week follow up
Botulinum Toxin A Then Placebo5.66.65.85.25.6777.36.7
Placebo Then Botulinum Toxin A5.72.72.74.35.72347

International Basic Pain Dataset - Pain Affecting Sleep

The International Basic Pain Dataset is an assessment tool which includes several components including: location of pain, temporal qualities of the pain, type of pain, pain interference measures of activity, sleep, and mood. It has been shown to be valid in an interview/self -report format. The pain affecting sleep subset of the dataset is scored is from 0 to 10, with higher score indicating less favorable outcomes. (NCT02736890)
Timeframe: up to 12 weeks post-injection, for a total of 24 weeks from baseline

,
Interventionunits on a scale (Mean)
Baseline2 week post injection4 week post injection8 week post injection12 week post injectioncrossover 2 week follow upcrossover 4 week follow upcrossover 8 week follow upcrossover 12 week follow up
Botulinum Toxin A Then Placebo5.84.6566.28887.3
Placebo Then Botulinum Toxin A6.74.73.366.71345

Numeric Pain Rating Scale (NPRS)

Participant rated pain intensity from 0-10, with higher score indicating more pain (NCT02736890)
Timeframe: up to 12 weeks post-injection, for a total of 24 weeks from baseline

,
Interventionscore on a scale (Mean)
baseline2 week post injection4 week post injection8 week post injection12 week post injectioncrossover 2 week follow upcrossover 4 week follow upcrossover 8 week follow upcrossover 12 week follow up
Botulinum Toxin A Then Placebo7.66.45.65.65.6886.78
Placebo Then Botulinum Toxin A888885567

Patient-generated Index (PGI)

PGI measures activity affected by pain. Full score is 0 to 10000, with higher score indicating better function (NCT02736890)
Timeframe: up to 12 weeks post-injection, for a total of 24 weeks from baseline

,
Interventionscore on a scale (Mean)
Baseline2 week post injection4 week post injection8 week post injection12 week post injectioncrossover 2 week follow upcrossover 4 week follow upcrossover 8 week follow upcrossover 12 week follow up
Botulinum Toxin A Then Placebo425052405219372543303333.33333.33333.33333.3
Placebo Then Botulinum Toxin A150015501825280018003500375030001500

Change of Pain Intensity From Baseline to the End of Treatment Using the 11-point Numerical Pain Rating Scale (NPRS)

"The evaluation of the pain intensity was based on a 11-point Numerical Pain Rating Scale (NPRS score from 0= no pain to 10= the most intense pain imaginable). Patients recorded the NPRS score every day of treatment in their diary.~The improvement in the pain intensity is defined as a decrease in NPRS scores from baseline to the end of treatment." (NCT03720119)
Timeframe: Every day for 15 days

InterventionScore on a scale (Mean)
NPRS score of Day 1NPRS score of Day 2NPRS score of Day 3NPRS score of Day 4NPRS score of Day 5NPRS score of Day 6NPRS score of Day 7NPRS score of Day 8NPRS score of Day 9NPRS score of Day 10NPRS score of Day 11NPRS score of Day 12NPRS score of Day 13NPRS score of Day 14NPRS score of Day 15
Single Cohort6.75.45.04.74.13.93.63.63.63.43.23.23.33.02.8

Change of Pain Relief From Baseline to the End of Treatment Using the 5-point Visual Rating Scale (VRS)

"The evaluation of wound pain relief was based on a 5-point Visual Rating Scale (0 = none improvement; 4 = total relief).~Patients recorded the VRS score every day of treatment in their diary. The improvement in the pain relief was defined as a VRS scores at end of treatment significantly greater than 0." (NCT03720119)
Timeframe: Every day for 15 days

InterventionParticipants (Count of Participants)
Day 272404424Day 372404424Day 472404424Day 572404424Day 672404424Day 772404424Day 872404424Day 972404424Day 1072404424Day 1172404424Day 1272404424Day 1372404424Day 1472404424Day 1572404424
None reliefMildComplete reliefModerateA lot
Single Cohort23
Single Cohort28
Single Cohort20
Single Cohort24
Single Cohort30
Single Cohort18
Single Cohort2
Single Cohort31
Single Cohort5
Single Cohort17
Single Cohort39
Single Cohort6
Single Cohort21
Single Cohort33
Single Cohort9
Single Cohort16
Single Cohort35
Single Cohort7
Single Cohort25
Single Cohort10
Single Cohort22
Single Cohort12
Single Cohort14
Single Cohort11
Single Cohort3
Single Cohort13
Single Cohort15
Single Cohort4

Reviews

21 reviews available for lidocaine and Postherpetic Neuralgia

ArticleYear
Changing the paradigm in postherpetic neuralgia treatment: lidocaine 700 mg medicated plaster.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:10

    Topics: Anesthetics, Local; Chronic Pain; Humans; Lidocaine; Neuralgia, Postherpetic; Quality of Life

2022
Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.
    Current pain and headache reports, 2023, Volume: 27, Issue:9

    Topics: Aged; Analgesics; Antidepressive Agents, Tricyclic; Gabapentin; Humans; Lidocaine; Neuralgia, Posthe

2023
The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis.
    Pain physician, 2020, Volume: 23, Issue:6

    Topics: Bayes Theorem; Capsaicin; Humans; Lidocaine; Network Meta-Analysis; Neuralgia, Postherpetic; Pharmac

2020
Cost-effectiveness analysis of 5% lidocaine-medicated plaster compared with pregabalin for the treatment of post-herpetic neuralgia in China.
    Annals of palliative medicine, 2021, Volume: 10, Issue:4

    Topics: China; Cost-Benefit Analysis; gamma-Aminobutyric Acid; Humans; Lidocaine; Neuralgia, Postherpetic; P

2021
ZTlido--a new lidocaine patch for postherpetic neuralgia.
    The Medical letter on drugs and therapeutics, 2019, Mar-25, Volume: 61, Issue:1568

    Topics: Anesthetics, Local; Animals; Humans; Lidocaine; Neuralgia, Postherpetic; Transdermal Patch

2019
Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Postgraduate medicine, 2013, Volume: 125, Issue:5

    Topics: 2-Aminopurine; Acyclovir; Adult; Aged; Aged, 80 and over; Analgesics; Antiviral Agents; Cohort Studi

2013
WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia.
    The Cochrane database of systematic reviews, 2013, Oct-28, Issue:10

    Topics: Administration, Topical; Anesthetics, Local; Humans; Lidocaine; Neuralgia, Postherpetic

2013
Options in topical therapies in the management of patients with acute pain.
    Postgraduate medicine, 2013, Volume: 125, Issue:4 Suppl 1

    Topics: Acute Pain; Administration, Cutaneous; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal;

2013
Topical therapies in the management of chronic pain.
    Postgraduate medicine, 2013, Volume: 125, Issue:4 Suppl 1

    Topics: Administration, Cutaneous; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; C

2013
[Postherpetic neuralgia].
    Schmerz (Berlin, Germany), 2014, Volume: 28, Issue:1

    Topics: Administration, Topical; Aged; Analgesics; Analgesics, Opioid; Anticonvulsants; Antidepressive Agent

2014
Topical lidocaine for neuropathic pain in adults.
    The Cochrane database of systematic reviews, 2014, Jul-24, Issue:7

    Topics: Adult; Anesthetics, Local; Humans; Lidocaine; Neuralgia; Neuralgia, Postherpetic; Pain, Postoperativ

2014
Clinical practice. Postherpetic neuralgia.
    The New England journal of medicine, 2014, Oct-16, Volume: 371, Issue:16

    Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic

2014
Clinical practice. Postherpetic neuralgia.
    The New England journal of medicine, 2014, Oct-16, Volume: 371, Issue:16

    Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic

2014
Clinical practice. Postherpetic neuralgia.
    The New England journal of medicine, 2014, Oct-16, Volume: 371, Issue:16

    Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic

2014
Clinical practice. Postherpetic neuralgia.
    The New England journal of medicine, 2014, Oct-16, Volume: 371, Issue:16

    Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic

2014
Herpes zoster (shingles) and postherpetic neuralgia.
    Mayo Clinic proceedings, 2009, Volume: 84, Issue:3

    Topics: Administration, Topical; Adrenal Cortex Hormones; Analgesics; Anesthetics, Local; Anticonvulsants; A

2009
Clinical inquiries: What measures relieve postherpetic neuralgia?
    The Journal of family practice, 2009, Volume: 58, Issue:7

    Topics: Administration, Oral; Administration, Topical; Analgesics, Opioid; Antidepressive Agents, Tricyclic;

2009
Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.
    Drugs, 2009, Oct-22, Volume: 69, Issue:15

    Topics: Anesthetics, Local; Dose-Response Relationship, Drug; Humans; Lidocaine; Neuralgia, Postherpetic; Pa

2009
5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
    Acta neurologica Scandinavica, 2011, Volume: 123, Issue:5

    Topics: Administration, Cutaneous; Amines; Analgesics; Anesthetics, Local; Clinical Trials as Topic; Cyclohe

2011
Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
    Current medical research and opinion, 2011, Volume: 27, Issue:5

    Topics: Administration, Topical; Amines; Anesthetics, Local; Antidepressive Agents, Tricyclic; Capsaicin; Cl

2011
Review of current guidelines on the care of postherpetic neuralgia.
    Postgraduate medicine, 2011, Volume: 123, Issue:5

    Topics: Amines; Analgesics; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanecarb

2011
Topical pain management with the 5% lidocaine medicated plaster--a review.
    Current medical research and opinion, 2012, Volume: 28, Issue:6

    Topics: Administration, Topical; Anesthetics, Local; Bandages, Hydrocolloid; Humans; Lidocaine; Neuralgia; N

2012
Topical lidocaine for the treatment of postherpetic neuralgia.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Administration, Topical; Anesthetics, Local; Humans; Lidocaine; Neuralgia, Postherpetic

2007
Management of herpes zoster and postherpetic neuralgia.
    Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:6 Suppl

    Topics: Adrenal Cortex Hormones; Aged; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic

2007

Trials

29 trials available for lidocaine and Postherpetic Neuralgia

ArticleYear
Clinical Efficacy of Pulsed Radiofrequency Combined with Intravenous Lidocaine Infusion in the Treatment of Subacute Herpes Zoster Neuralgia.
    Pain research & management, 2022, Volume: 2022

    Topics: Analgesics; Calcitonin Gene-Related Peptide; Herpes Zoster; Humans; Infusions, Intravenous; Interleu

2022
Local Administration of Methylcobalamin for Subacute Ophthalmic Herpetic Neuralgia: A Randomized, Phase III Clinical Trial.
    Pain practice : the official journal of World Institute of Pain, 2020, Volume: 20, Issue:8

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Analgesics; Anesthetics, Local; Female; Herpe

2020
Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia.
    Pain physician, 2017, Volume: 20, Issue:5

    Topics: Aged; Anesthetics, Local; China; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injecti

2017
The Analgesic and Emotional Response to Intravenous Lidocaine Infusion in the Treatment of Postherpetic Neuralgia: A Randomized, Double-Blinded, Placebo-controlled Study.
    The Clinical journal of pain, 2018, Volume: 34, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Anxiety; Depression; Double-Blind Method; Emotio

2018
Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2019, Volume: 66, Issue:7

    Topics: Aged; Anesthetics, Local; Chronic Pain; Cross-Over Studies; Diabetic Neuropathies; Diphenhydramine;

2019
The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:4

    Topics: Aged; Aged, 80 and over; Anesthetics, Local; Cross-Over Studies; Double-Blind Method; Female; Humans

2013
A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
    European journal of pain (London, England), 2013, Volume: 17, Issue:10

    Topics: Aged; Aged, 80 and over; Capsaicin; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Ma

2013
Transcutaneous electrical nerve stimulation in combination with cobalamin injection for postherpetic neuralgia: a single-center randomized controlled trial.
    American journal of physical medicine & rehabilitation, 2014, Volume: 93, Issue:4

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anesthetics, Local; Combined Modality Therapy;

2014
Local Administration of Methylcobalamin and Lidocaine for Acute Ophthalmic Herpetic Neuralgia: A Single-Center Randomized Controlled Trial.
    Pain practice : the official journal of World Institute of Pain, 2016, Volume: 16, Issue:7

    Topics: Aged; Anesthetics, Local; Female; Herpes Zoster Ophthalmicus; Humans; Incidence; Lidocaine; Male; Mi

2016
Local Injection of Methylcobalamin Combined with Lidocaine for Acute Herpetic Neuralgia.
    Pain medicine (Malden, Mass.), 2016, Volume: 17, Issue:3

    Topics: Acute Disease; Aged; Anesthetics, Local; Drug Therapy, Combination; Female; Humans; Injections, Subc

2016
Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
    Pain management, 2016, Volume: 6, Issue:3

    Topics: Administration, Cutaneous; Aged; Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine;

2016
[Efficacy of intracutaneous methylene blue injection for moderate to severe acute thoracic herpes zoster pain and prevention of postherpetic neuralgia in elderly patients].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016, Oct-20, Volume: 36, Issue:10

    Topics: Acyclovir; Aged; Herpes Zoster; Humans; Incidence; Injections, Intradermal; Lidocaine; Methylene Blu

2016
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.
    European journal of drug metabolism and pharmacokinetics, 2017, Volume: 42, Issue:5

    Topics: Aged; Aged, 80 and over; Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine; Male; M

2017
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Clinical drug investigation, 2009, Volume: 29, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Analgesics; Anesthetics, Local; Capsules; Dia

2009
Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
    Current medical research and opinion, 2009, Volume: 25, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Anesthetics, Local; Bandages; Female; Follow-Up St

2009
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
    Clinical drug investigation, 2009, Volume: 29, Issue:6

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Anesthetics, Local; Double-Blind Method; Drug Ad

2009
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Current medical research and opinion, 2009, Volume: 25, Issue:7

    Topics: Aged; Algorithms; Analgesics; Casts, Surgical; Diabetic Neuropathies; Drug Combinations; Female; gam

2009
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Current medical research and opinion, 2009, Volume: 25, Issue:7

    Topics: Aged; Algorithms; Analgesics; Casts, Surgical; Diabetic Neuropathies; Female; gamma-Aminobutyric Aci

2009
Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    European journal of anaesthesiology, 2010, Volume: 27, Issue:2

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anesthetics, Local; Data Collection; Eryt

2010
Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Clinical drug investigation, 2010, Volume: 30, Issue:2

    Topics: Administration, Topical; Analgesics; Anesthetics, Local; Cost-Benefit Analysis; Data Interpretation,

2010
Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia.
    Anesthesia and analgesia, 2010, May-01, Volume: 110, Issue:5

    Topics: Aged; Aged, 80 and over; Anesthetics, Local; Cross-Over Studies; Double-Blind Method; Eye Diseases;

2010
Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
    Current medical research and opinion, 2010, Volume: 26, Issue:7

    Topics: Administration, Topical; Aged; Anesthetics, Combined; Anesthetics, Local; Dosage Forms; Female; gamm

2010
Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Pain medicine (Malden, Mass.), 2010, Volume: 11, Issue:12

    Topics: Analgesics, Opioid; Anesthetics, Local; Botulinum Toxins, Type A; Double-Blind Method; Humans; Injec

2010
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
    Current medical research and opinion, 2012, Volume: 28, Issue:8

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Anesthetics, Local; Casts, Surgical; Dose-Respon

2012
Proteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic pain.
    Proteomics, 2012, Volume: 12, Issue:19-20

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Anesthetics, Local; Anti-Inflammatory Agents; Blottin

2012
No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients.
    European journal of pain (London, England), 2013, Volume: 17, Issue:5

    Topics: Aged; Aged, 80 and over; Cytokines; Female; Follow-Up Studies; Humans; Lidocaine; Male; Methylpredni

2013
The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2005, Volume: 15, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Anti-Inflammatory Agents; Drug Therapy, Combinat

2005
Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.
    The journal of pain, 2007, Volume: 8, Issue:2

    Topics: Administration, Topical; Adult; Aged; Anesthetics, Local; Diabetic Neuropathies; Female; Humans; Lid

2007
Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.
    Pain, 2007, Volume: 128, Issue:1-2

    Topics: Action Potentials; Administration, Cutaneous; Aged; Aged, 80 and over; Anesthetics, Local; Brain; Br

2007

Other Studies

37 other studies available for lidocaine and Postherpetic Neuralgia

ArticleYear
Localized peripheral neuropathic pain: topical treatment with lidocaine 700 mg medicated plaster in routine clinical practice.
    Pain management, 2022, Volume: 12, Issue:4

    Topics: Anesthetics, Local; Cohort Studies; Humans; Lidocaine; Neuralgia; Neuralgia, Postherpetic; Quality o

2022
Lidocaine 700 mg medicated plaster for post-herpetic neuralgia: focus on Quality of Life, effectiveness and safety - a retrospective observational study.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:1

    Topics: Humans; Lidocaine; Neuralgia, Postherpetic; Quality of Life; Retrospective Studies; Treatment Outcom

2022
Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia.
    Medicine, 2022, Jun-10, Volume: 101, Issue:23

    Topics: Anesthetics, Local; Humans; Lidocaine; Neuralgia, Postherpetic; Retrospective Studies; Ropivacaine;

2022
Postsurgical neuropathic pain: lidocaine 700 mg medicated plaster or oral treatments in clinical practice.
    Pain management, 2022, Volume: 12, Issue:6

    Topics: Anesthetics, Local; Cohort Studies; Humans; Lidocaine; Neuralgia; Neuralgia, Postherpetic; Quality o

2022
Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments.
    BMJ open diabetes research & care, 2022, Volume: 10, Issue:6

    Topics: Analgesics; Cohort Studies; Diabetes Mellitus; Diabetic Neuropathies; Humans; Lidocaine; Neuralgia,

2022
Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.
    Journal of managed care & specialty pharmacy, 2019, Volume: 25, Issue:12

    Topics: Aged; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Female; Health Care C

2019
Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland.
    Applied health economics and health policy, 2021, Volume: 19, Issue:1

    Topics: Adult; Costs and Cost Analysis; Health Expenditures; Humans; Ireland; Lidocaine; Neuralgia, Postherp

2021
Caudal block with steroid in the treatment of acute voiding dysfunction and pain caused by sacral herpes zoster: A case report.
    Medicine, 2020, Jun-19, Volume: 99, Issue:25

    Topics: Anesthesia, Caudal; Anesthetics, Local; Fluoroscopy; Glucocorticoids; Herpes Zoster; Humans; Lidocai

2020
Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia.
    Dermatologic therapy, 2021, Volume: 34, Issue:1

    Topics: Herpes Zoster; Humans; Lidocaine; Neuralgia; Neuralgia, Postherpetic

2021
Thermographic follow-up of postherpetic neuralgia (PHN) subsequent to Ramsay Hunt syndrome with multicranial nerve (V, VII, VIII and IX) involvement: a case report.
    BMC neurology, 2021, Jan-28, Volume: 21, Issue:1

    Topics: Aged; Analgesics; Anesthetics, Local; Follow-Up Studies; Gabapentin; Herpes Zoster Oticus; Humans; L

2021
Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry.
    Pain management, 2022, Volume: 12, Issue:2

    Topics: Anesthetics, Local; Humans; Lidocaine; Neuralgia, Postherpetic; Quality of Life; Registries; Retrosp

2022
Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
    European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:18

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Local; Female; Humans; Hyperalgesia; Lidoca

2017
Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report
    Acta clinica Croatica, 2016, Volume: 55, Issue:4

    Topics: Administration, Cutaneous; Aged, 80 and over; Anesthetics, Local; Diagnosis, Differential; Female; H

2016
Very late sensitization to parabens induced by repeated applications of an anaesthetic therapeutic plaster to non-damaged skin.
    Contact dermatitis, 2018, Volume: 79, Issue:3

    Topics: Administration, Cutaneous; Anesthetics, Local; Dermatitis, Contact; Female; Humans; Lidocaine; Middl

2018
Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
    Minerva medica, 2018, Volume: 109, Issue:5

    Topics: Aged; Analgesics; Anesthetics, Local; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; E

2018
[Postherpetic neuralgia of the left trigeminus nerve V1 : Successful therapy with capsaicin 8% patch].
    Schmerz (Berlin, Germany), 2018, Volume: 32, Issue:6

    Topics: Aged; Capsaicin; Humans; Lidocaine; Neuralgia, Postherpetic; Quality of Life; Trigeminal Nerve

2018
[Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Minerva medica, 2013, Volume: 104, Issue:6

    Topics: Administration, Cutaneous; Aged; Anesthetics, Local; Calcium Sulfate; Drug Carriers; Female; Humans;

2013
[Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Minerva medica, 2014, Volume: 105, Issue:6

    Topics: Administration, Cutaneous; Adult; Aged; Anesthetics, Local; Blood Vessel Prosthesis Implantation; Br

2014
Prevalence and impact on quality of life of post-herpetic neuralgia in French medical centers specialized in chronic pain management: the ZOCAD study.
    Medecine et maladies infectieuses, 2014, Volume: 44, Issue:11-12

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics; Anesthetics, Local; Anticonvu

2014
5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study.
    Neurologia i neurochirurgia polska, 2015, Volume: 49, Issue:1

    Topics: Administration, Cutaneous; Aged; Anesthetics, Local; Autonomic Nerve Block; Bandages; Bupivacaine; E

2015
[Shingles symptoms are gone but not the pain].
    MMW Fortschritte der Medizin, 2015, Jul-23, Volume: 157, Issue:13

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Amines; Amitriptyline; Analgesics; Anti-Infla

2015
Ultrasound-Guided Musculocutaneous Nerve Block in Postherpetic Neuralgia.
    American journal of physical medicine & rehabilitation, 2016, Volume: 95, Issue:1

    Topics: Aged, 80 and over; Anesthetics, Local; Glucocorticoids; Humans; Lidocaine; Male; Musculocutaneous Ne

2016
Gasserian Ganglion and Retrobulbar Nerve Block in the Treatment of Ophthalmic Postherpetic Neuralgia: A Case Report.
    Pain practice : the official journal of World Institute of Pain, 2017, Volume: 17, Issue:7

    Topics: Aged, 80 and over; Analgesics; Anesthetics, Local; Female; Follow-Up Studies; Humans; Lidocaine; Ner

2017
Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.
    Current medical research and opinion, 2017, Volume: 33, Issue:3

    Topics: Aged; Anesthetics, Local; Clinical Trials as Topic; Female; Humans; Lidocaine; Male; Neuralgia, Post

2017
Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
    Clinical drug investigation, 2008, Volume: 28, Issue:9

    Topics: Administration, Cutaneous; Amines; Analgesics; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; D

2008
[Effects of percutaneous lidocaine administration and xenon-ray irradiation on post-herpetic neuralgia in liver transplant recipients: a report of three cases].
    Masui. The Japanese journal of anesthesiology, 2009, Volume: 58, Issue:1

    Topics: Adolescent; Aged; Anesthetics, Local; Female; Humans; Immunocompromised Host; Iontophoresis; Lidocai

2009
Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
    Journal of medical economics, 2010, Volume: 13, Issue:3

    Topics: Amines; Analgesics; Costs and Cost Analysis; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-

2010
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%.
    Journal of medical economics, 2010, Volume: 13, Issue:3

    Topics: Aged; Analysis of Variance; Anesthetics, Local; Comorbidity; Female; Health Care Costs; Humans; Insu

2010
[Modified van-Lint technique for the management of postherpetic neuralgia: case report].
    Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2011, Volume: 23, Issue:2

    Topics: Aged; Anesthetics, Local; Female; Herpes Zoster; Humans; Lidocaine; Nerve Block; Neuralgia, Postherp

2011
5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
    Drugs & aging, 2011, Sep-01, Volume: 28, Issue:9

    Topics: Aged; Anticonvulsants; Antidepressive Agents; Calcium Sulfate; Compassionate Use Trials; Female; Fra

2011
Modified Jaipur block for the treatment of post-herpetic neuralgia.
    International journal of dermatology, 2011, Volume: 50, Issue:11

    Topics: Adult; Anesthetics, Local; Anti-Inflammatory Agents; Autonomic Nerve Block; Bupivacaine; Female; Hum

2011
Prevention and treatment of postherpetic neuralgia.
    Lancet (London, England), 2006, Jan-21, Volume: 367, Issue:9506

    Topics: Adult; Amines; Anesthetics, Local; Antiviral Agents; Calcium Channel Blockers; Child, Preschool; Cyc

2006
Lidocaine patch for treatment of postherpetic neuralgia?
    American family physician, 2006, Aug-01, Volume: 74, Issue:3

    Topics: Administration, Cutaneous; Anesthetics, Local; Humans; Lidocaine; Neuralgia, Postherpetic; Treatment

2006
Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
    Clinical therapeutics, 2007, Volume: 29, Issue:7

    Topics: Administration, Cutaneous; Aged; Amines; Analgesics; Anesthetics, Local; Cost-Benefit Analysis; Cycl

2007
A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Clinical therapeutics, 2007, Volume: 29, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Amines; Analgesics; Analgesics, Opioid; Anticonvulsants;

2007
Lidocaine plasters for postherpetic neuralgia?
    Drug and therapeutics bulletin, 2008, Volume: 46, Issue:2

    Topics: Administration, Topical; Anesthetics, Local; Bandages; Humans; Lidocaine; Neuralgia, Postherpetic

2008
The lidocaine patch #148.
    Journal of palliative medicine, 2008, Volume: 11, Issue:3

    Topics: Administration, Cutaneous; Delayed-Action Preparations; Drug Evaluation; Humans; Lidocaine; Neuralgi

2008